Danna Jennings
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Autism Spectrum Disorder Research, Genetic Neurodegenerative Diseases, Botulinum Toxin and Related Neurological Disorders
Most-Cited Works
- → The Parkinson Progression Marker Initiative (PPMI)(2011)1,829 cited
- → The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort(2018)651 cited
- → A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research(2024)501 cited
- → Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects(2012)393 cited
- → Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition(2017)358 cited
- → Cognitive performance of GBA mutation carriers with early-onset PD(2012)265 cited
- → Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease(2022)237 cited
- → Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline(2012)228 cited
- → CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study(2016)215 cited
- → Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort(2018)201 cited